Biocon

Biocon, Mylan enhance partnership with insulin products collaboration

Friday, February 15, 2013 11:45 AM

Biocon, a biotechnology company based in India, has formed a strategic collaboration with Mylan, a global pharmaceutical company, for for the global development and commercialization of generic versions of its three insulin analog products.

More... »


Biocon opens research center in India, seeks 300 scientists

Friday, April 6, 2012 01:00 PM

Biocon, an Asia-based biotech, has opened the doors of its Integrated Research and Development Centre, Biocon Research Centre (BRC) in India, aimed at pursuing world class research on biologics that will address unmet medical needs.

More... »


Biocon and Pfizer conclude commercialization agreement

Thursday, March 15, 2012 06:01 AM

India-based biotech Biocon and Pfizer have concluded their alliance to commercialize Biocon's biosimilar versions of insulin and insulin analog products.

More... »

Spaulding Clinical Research partners with Clinigene

Tuesday, August 23, 2011 11:04 AM

Spaulding Clinical Research has partnered with Clinigene International, part of the Biocon, based in Bangalore, India, to broaden and globalize its research services offering, according to PharmaTimes.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs